M.D.C. - MDC Stock Forecast, Price & News

M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, Washington, Colorado, Idaho, Utah, Maryland, Pennsylvania, Virginia, Tennessee, and Florida. Its financial services operations comprise originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, and Virginia. M.D.C. Holdings, Inc. was founded in 1972 and is headquartered in Denver, Colorado.

M.D.C. Stock Down 1.2 %

MDC traded down $0.42 on Friday, reaching $34.47. The company's stock had a trading volume of 677 shares, compared to its average volume of 502,696. The stock has a 50 day moving average of $34.10 and a two-hundred day moving average of $37.84. The company has a quick ratio of 1.46, a current ratio of 7.31 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $2.45 billion, a price-to-earnings ratio of 3.96 and a beta of 1.37. M.D.C. has a fifty-two week low of $27.83 and a fifty-two week high of $56.53.

M.D.C. (NYSE:MDC - Get Rating) last posted its quarterly earnings data on Thursday, July 28th. The construction company reported $2.59 earnings per share for the quarter, beating the consensus estimate of $2.50 by $0.09. The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.43 billion. M.D.C. had a return on equity of 24.31% and a net margin of 11.71%. The company's revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.11 earnings per share. As a group, analysts forecast that M.D.C. will post 9.64 EPS for the current fiscal year.

M.D.C. Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 24th. Stockholders of record on Wednesday, August 10th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 5.80%. The ex-dividend date of this dividend is Tuesday, August 9th. M.D.C.'s dividend payout ratio (DPR) is presently 22.70%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on MDC. JPMorgan Chase & Co. cut their target price on shares of M.D.C. from $40.50 to $38.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 12th. Wells Fargo & Company lowered shares of M.D.C. from an "equal weight" rating to an "underweight" rating and set a $27.00 target price on the stock. in a research note on Friday, June 17th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, M.D.C. currently has a consensus rating of "Hold" and a consensus price target of $47.33.

Insider Transactions at M.D.C.

In other news, Director Raymond T. Baker sold 33,067 shares of the company's stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $35.59, for a total transaction of $1,176,854.53. Following the completion of the sale, the director now owns 40,187 shares in the company, valued at $1,430,255.33. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director David Siegel sold 6,500 shares of the firm's stock in a transaction on Monday, August 15th. The stock was sold at an average price of $35.40, for a total value of $230,100.00. Following the completion of the transaction, the director now owns 16,519 shares in the company, valued at $584,772.60. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Raymond T. Baker sold 33,067 shares of the firm's stock in a transaction on Friday, July 29th. The shares were sold at an average price of $35.59, for a total value of $1,176,854.53. Following the completion of the transaction, the director now owns 40,187 shares of the company's stock, valued at approximately $1,430,255.33. The disclosure for this sale can be found here. Company insiders own 24.20% of the company's stock.